Differential gene expression in skeletal muscle of rats with vitamin E deficiency

IUBMB Life

Volumn 58, Issue 9, 2006, Pages 540-548

  Nier, Bettina ^a   Weinberg, Peter D ^a   Rimbach, Gerald ^b   Stöcklin, Elisabeth ^c   Barella, Luca ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Differential gene expression; Myopathy; Vitamin E deficiency

Indexed keywords

ALPHA TOCOPHEROL;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; MALE; MOLECULAR PROBE; MYOPATHY; NONHUMAN; RAT; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MUSCLE, SKELETAL; MUSCLES; MUSCULAR DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; RATS; TIME FACTORS; VITAMIN E; VITAMIN E DEFICIENCY;

ANIMALIA;

EID: 33749135034     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600871100     Document Type: Article

References (58)

1. Brigelius-Flohe, R., and Traber, M. G. (1999) Vitamin E: function and metabolism. FASEB J. 13, 1145-1155.
2. Rumery, R. E., and Hampton, J. C. (1959) Microscopic and submicroscopic observations on skeletal muscle from vitamin E deficient rats. Anat. Rec. 133, 1-7.
3. Machlin, L. J., Filipski, R., Nelson, J., Horn, L. R., and Brin, M. (1977) Effects of a prolonged vitamin E deficiency in the rat. J. Nutr. 107, 1200-1208.
4. Van Vleet, J. F., Hall, B. V., and Simon, J. (1968) Vitamin E deficiency. A sequential light and electron microscopic study of skeletal muscle degeneration in weanling rabbits. Am. J. Pathol. 52, 1067-1079.
5. Van Vleet, J. F., and Ferrans, V. J. (1992) Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans. Biol. Trace Elem. Res. 33, 1-21.
6. Sharp, D., Blinderman, L., Combs, K. A., Kienzle, B., Ricci, B., Wager-Smith, K., Gil, C. M., Turck, C. W., Bouma, M. E. et al. (1993) Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 365, 65-69.
7. Sokol, R. J. (2006) Vitamin E deficiency and neurological disorders. In: Vitamin E in health and disease (Packer, L., and Fuchs, J., eds.), pp. 815-849. Marcel Dekker, New York.
8. Ouahchi, K., Arita, M., Kayden, H., Hentati, F., Ben, H. M., Sokol, R., Arai, H., Inoue, K., Mandel, J. L., and Koenig, M. (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat. Genet. 9, 141-145.
9. Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A. (1991) Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266, 6188-6194.
10. Ricciarelli, R., Zingg, J. M., and Azzi, A. (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102, 82-87.
11. Shaw, H. M., and Huang, C. (1998) Liver alpha-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. J. Nutr. 128, 2348-2354.
12. Chojkier, M., Houglum, K., Lee, K. S., and Buck, M. (1998) Long-and short-term D-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. Am. J. Physiol. 275, G1480-G1485.
13. Ricciarelli, R., Maroni, P., Ozer, N., Zingg, J. M., and Azzi, A. (1999) Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic. Biol. Med. 27, 729-737.
14. Aratri, E., Spycher, S. E., Breyer, I., and Azzi, A. (1999) Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett. 447, 91-94.
15. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951.
16. Barella, L., Muller, P. Y., Schlachter, M., Hunziker, W., Stocklin, E., Spitzer, V., Meier, N., de Pascual-Teresa, S., Minihane, A. M., and Rimbach, G. (2004) Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats. Biochim. Biophys. Acta 1689, 66-74.
17. Chen, Y. W., Zhao, P., Borup, R., and Hoffman, E. P. (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336.
18. Goetsch, S. C., Hawke, T. J., Gallardo, T. D., Richardson, J. A., and Garry, D. J. (2003) Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics 14, 261-271.
19. Suzuki, N., Aoki, M., Hinuma, Y., Takahashi, T., Onodera, Y., Ishigaki, A., Kato, M., Warita, H., Tateyama, M., and Itoyama, Y. (2005) Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Neurosci. Res. 52, 47-60.
20. Rota, C., Barella, L., Minihane, A. M., Stocklin, E., and Rimbach, G. (2004) Dietary alpha-tocopherol affects differential gene expression in rat testes. IUBMB Life 56, 277-280.
21. Navarro-Arevalo, A., Canavate, C., and Sanchez-del-Pino, M. J. (1999) Myocardial and skeletal muscle aging and changes in oxidative stress in relationship to rigorous exercise training. Mech. Ageing Dev. 108, 207-217.
22. Fischer, A., Pallauf, J., Gohil, K., Weber, S. U., Packer, L., and Rimbach, G. (2001) Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem. Biophys. Res. Commun. 285, 470-475.
23. Toyofuku, T., Hoffman, J. R., Zak, R., and Carlson, B. M. (1992) Expression of alpha-cardiac and alpha-skeletal actin mRNAs in relation to innervation in regenerating and non-regenerating rat skeletal muscles. Dev. Dyn. 193, 332-339.
24. Whalen, R. G., Schwartz, K., Bouveret, P., Sell, S. M., and Gros, F. (1979) Contractile protein isozymes in muscle development: identification of an embryonic form of myosin heavy chain. Proc. Natl. Acad. Sci. USA 76, 5197-5201.
25. Carrino, D. A., Sorrell, J. M., and Caplan, A. I. (1999) Dynamic expression of proteoglycans during chicken skeletal muscle development and maturation. Poult. Sci. 78, 769-777.
26. Franco, A. A., Odom, R. S., and Rando, T. A. (1999) Regulation of antioxidant enzyme gene expression in response to oxidative stress and during differentiation of mouse skeletal muscle. Free Radic. Biol. Med. 27, 1122-1132.
27. Martin, P. (1997) Wound healing-aiming for perfect skin regeneration. Science 276, 75-81.
28. Michalopoulos, G. K., and DeFrances, M. C. (1997) Liver regeneration. Science 276, 60-66.
29. Reddi, A. H. (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16, 247-252.
30. Arber, S., and Caroni, P. (1995) Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth. J. Cell Biol. 131, 1083-1094.
31. Baumeister, A., Arber, S., and Caroni, P. (1997) Accumulation of muscle ankyrin repeat protein transcript reveals local activation of primary myotube endcompartments during muscle morphogenesis. J. Cell Biol. 139, 1231-1242.
32. McCawley, L. J., and Matrisian, L. M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534-540.
33. Iredale, J. P. (1997) Tissue inhibitors of metalloproteinases in liver fibrosis. Int. J. Biochem. Cell Biol. 29, 43-54.
34. Lichtinghagen, R., Breitenstein, K., Arndt, B., Kuhbacher, T., and Boker, K. H. (1998) Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch. 432, 153-158.
35. von, M. A., Zwirner, A., Reinhold, A., Bruckmann, O., van, L. F., Stoltenburg-Didinger, G., Schuppan, D., Herbst, H., and Schuelke, M. (2005) Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy. Acta Neuropathol. (Berl) 109, 285-293.
36. Ishiguro, N., Baba, T., Ishida, T., Takeuchi, K., Osaki, M., Araki, N., Okada, E., Takahashi, S., Saito, M. et al. (2002) Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. Am. J. Pathol. 160, 1767-1778.
37. Tsukamoto, Y., Senda, T., Nakano, T., Nakada, C., Hida, T., Ishiguro, N., Kondo, G., Baba, T., Sato, K. et al. (2002) Arpp, a new homolog of carp, is preferentially expressed in type 1 skeletal muscle fibers and is markedly induced by denervation. Lab. Invest. 82, 645-655.
38. Nakada, C., Tsukamoto, Y., Oka, A., Nonaka, I., Takeda, S., Sato, K., Mori, S., Ito, H., and Moriyama, M. (2003) Cardiac-restricted ankyrin-repeated protein is differentially induced in duchenne and congenital muscular dystrophy. Lab. Invest. 83, 711-719.
39. Du, B., Fu, C., Kent, K. C., Bush, H., Jr., Schulick, A. H., Kreiger, K., Collins, T., and McCaffrey, T. A. (2000) Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J. Biol. Chem. 275, 39039-39047.
40. Gashler, A., and Sukhatme, V. P. (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191-224.
41. Khachigian, L. M., Lindner, V., Williams, A. J., and Collins, T. (1996) Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271, 1427-1431.
42. Okada, M., Wang, C. Y., Hwang, D. W., Sakaguchi, T., Olson, K. E., Yoshikawa, Y., Minamoto, K., Mazer, S. P., Yan, S. F., and Pinsky, D. J. (2002) Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ. Res. 91, 135-142.
43. Silverman, E. S., and Collins, T. (1999) Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154, 665-670.
44. Aicher, W. K., Alexander, D., Haas, C., Kuchen, S., Pagenstecher, A., Gay, S., Peter, H. H., and Eibel, H. (2003) Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts. Arthritis Rheum. 48, 348-359.
45. Lo, L. W., Cheng, J. J., Chiu, J. J., Wung, B. S., Liu, Y. C., and Wang, D. L. (2001) Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway. J. Cell Physiol. 188, 304-312.
46. Chou, A. C., Broun, G. O., Jr., and Fitch, C. D. (1978) Abnormalities of iron metabolism and erythropoiesis in vitamin E-deficient rabbits. Blood 52, 187-195.
47. Li, R.K., Cowan, D.B., Mickle, D. A., Weisel, R. D., and Burton, G.W. (1996) Effect of vitamin E on human glutathione peroxidase (GSH-PX1) expression in cardiomyocytes. Free Radic. Biol. Med. 21, 419-426.
48. Bulfield, G., Siller, W. G., Wight, P. A., and Moore, K. J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192.
49. Hoffman, E. P., and Schwartz, L. (1991) Dystrophin and disease. Mol. Aspects Med. 12, 175-194.
50. Tseng, B. S., Zhao, P., Pattison, J. S., Gordon, S. E., Granchelli, J. A., Madsen, R. W., Folk, L. C., Hoffman, E. P., and Booth, F. W. (2002) Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J. Appl. Physiol. 93, 537-545.
51. Russo-Marie, F. (1992) Annexins, phospholipase A2 and the glucocorticoids. In: The Annexins (Moss, S. E., ed.), pp. 35-46. Portland Press, London and Chapel Hill.
52. Tschope, C., Walther, T., Escher, F., Spillmann, F., Du, J., Altmann, C., Schimke, I., Bader, M., Sanchez-Ferrer, C. F. et al. (2005) Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J. 19, 2057-2059.
53. Chao, J., and Chao, L. (2006) Experimental therapy with tissue kallikrein against cerebral ischemia. Front Biosci. 11, 1323-1327.
54. Tschesche, H., Michaelis, J., Kohnert, U., Fedrowitz, J., and Oberhoff, R. (1989) Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv. Exp. Med. Biol. 247A, 545-548.
55. Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001) The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol. Chem. 382, 5-14.
56. Kempna, P., Zingg, J. M., Ricciarelli, R., Hierl, M., Saxena, S., and Azzi, A. (2003) Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic. Biol. Med. 34, 1458-1472.
57. Stocker, A., Zimmer, S., Spycher, S. E., and Azzi, A. (1999) Identification of a novel cytosolic tocopherol-binding protein: structure, specificity, and tissue distribution. IUBMB Life 48, 49-55.
58. Zimmer, S., Stocker, A., Sarbolouki, M. N., Spycher, S. E., Sassoon, J., and Azzi, A. (2000) A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 275, 25672-25680.